Drug interactions
Pantoprazole + Tafamidis meglumine
Severity: Minor
Pantoprazole and Tafamidis meglumine: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Tafamidis meglumine inhibits BCRP in vitro and may raise exposure to BCRP substrates such as pantoprazole. Clinical relevance is likely small given the wide therapeutic margin of pantoprazole.
What this interaction means in plain words
Pantoprazole and Tafamidis meglumine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Why it happens
Inhibition of BCRP-mediated efflux of pantoprazole by tafamidis.
What to do
No routine adjustment is required. Monitor for pantoprazole adverse effects if high doses are used.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Pantoprazole and Tafamidis meglumine, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Pantoprazole
- Pantoprazole + Rilpivirine Contraindicated
- Acalabrutinib + Pantoprazole Major
- Atazanavir + Pantoprazole Major
- Dacomitinib + Pantoprazole Major
- Dasatinib + Pantoprazole Major
- Erlotinib + Pantoprazole Major
Frequently asked questions
Can I take Pantoprazole with Tafamidis meglumine?
MediHelp rates the interaction as minor. Pantoprazole and Tafamidis meglumine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Tafamidis meglumine inhibits BCRP in vitro and may raise exposure to BCRP substrates such as pantoprazole. Clinical relevance is likely small given the wide therapeutic margin of pantoprazole.
How serious is the interaction between Pantoprazole and Tafamidis meglumine?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine adjustment is required. Monitor for pantoprazole adverse effects if high doses are used.
What other medicines interact with Pantoprazole?
MediHelp also lists interactions of Pantoprazole with, for example, Rilpivirine, Acalabrutinib, Atazanavir. The full list is on the Pantoprazole page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
